FDA
-
-
-
-
-
-
-
Biocon Biologics recieves FDA approval for Jobevne
-
-
-
-
-
-
-
Mylan (MYL) and Biocon Announce FDA Approval for Ogivri to Treat HER2-Positive Breast and Gastric Cancers
-
-
-
-
-
328,282 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

